Sarcoma: all 1,691 studies
Page 10 of 17. Open to participants first (393), then studies with results posted, then the rest; newest registration first within each.
- Study on TSR-042 in Advanced Clear Cell SarcomaTerminatedNCT04274023Phase 2
- A Study to Evaluate the Safety and Pharmacokinetics of OC-001 in Patients With Locally Advanced or Metastatic CancersTerminatedNCT04260802Phase 1/2
- Prehabilitation to Improve Cancer Surgery Outcomes in AYA Patients With Extremity SarcomasCompletedNCT04248959Not applicable
- Study of DCC-3014 in Combination With Avelumab in Patients With Advanced or Metastatic SarcomasCompletedNCT04242238Phase 1
- Clinical Study of PD-1 Monoclonal Antibody SHR-1210 and Apatinib in Advanced NSCLC, Soft Tissue Sarcoma, and Uterine CancerStatus unknownNCT04239443Phase 2
- Perioperative Residual Adrenal Function After Extended Resection for Retroperitoneal Soft Tissue SarcomasCompletedNCT04225494
- Tazemetostat Expanded Access Program for Adults With Epithelioid SarcomaNo longer availableNCT04225429
- The PET- Retroperitoneal Sarcoma StudyCompletedNCT04224948Not applicable
- Study on the Treatment of Soft Tissue Sarcoma With First-line Chemotherapy Failure by Anrotenil Hydrochloride CapsuleCompletedNCT04223583Phase 4
- MEK Inhibitor and a PDL1 Inhibitor Patients With Locally Advanced and/or Metastatic Soft Tissue SarcomaCompletedNCT04216953Phase 1/2
- Heated Intra-peritoneal Chemotherapy with Doxorubicin and Cisplatin for Abdominal for Pelvic Tumors in Pediatric PatientsTerminatedNCT04213794Early Phase 1
- BIO-11006 for Osteosarcoma and Ewing's Sarcoma Lung MetastasesWithdrawnNCT04183062Phase 2
- Phase I Study of Radiolabeled OTSA101-DTPA in Patients With Relapsed or Refractory Synovial SarcomaTerminatedNCT04176016Phase 1
- Anlotinib Combined With Toripalimab in Refractory and Advanced Soft-tissue SarcomaCompletedNCT04172805Phase 2
- Evaluation of AL3818 in Combination With Nivolumab in Solid TumorsActive, not recruitingNCT04165330Phase 1/2
- Safety, PK and Efficacy of ONC-392 in Monotherapy and in Combination of Anti-PD-1 in Advanced Solid Tumors and NSCLCActive, not recruitingNCT04140526Phase 1/2
- Selinexor as Single Agent and With Imatinib in Metastatic and/or Unresectable Gastrointestinal Stromal Tumors (SeliGIST)Active, not recruitingNCT04138381Phase 1/2
- Study of SHR-1210 Combined With Apatinib in the Treatment of SarcomaStatus unknownNCT04126993Phase 2
- Apatinib Combined With Chemotherapy in the Treatment of Soft Tissue SarcomaStatus unknownNCT04126811Phase 2
- Focused Ultrasound to Promote Immune Responses for Undifferentiated Pleomorphic SarcomaTerminatedNCT04123535Not applicable
- Children and Adolescents With Leukemia, Brain Tumors, and SarcomasCompletedNCT04101123
- Combination of Nivolumab Plus Relatlimab in Patients With Advanced or Metastatic Soft-tissue Sarcoma: a Proof-of-concept Randomized Phase II StudyCompletedNCT04095208Phase 2
- Indocyanine Green (ICG) Guided Tumor ResectionCompletedNCT04084067Phase 1
- Assessing Health-related Quality of Life in Sarcoma PatientsCompletedNCT04071704
- Phase II Multicenter Study of Talimogene Laherparepvec in Classic or Endemic Kaposi SarcomaStatus unknownNCT04065152Phase 2
- Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue SarcomaActive, not recruitingNCT04055753
- Gemcitabine and Docetaxel With Radiation in Adults With Soft Tissue Sarcoma of the ExtremitiesTerminatedNCT04037527Phase 1
- Registry of Sarcoma Patients Treated With Permanently Implantable LDR CivaSheet®Active, not recruitingNCT04033081Phase 4
- Dose Finding Study of L19TNF and Doxorubicin in Patients With STSActive, not recruitingNCT04032964Phase 1
- The Registry of Oncology Outcomes Associated with Testing and TreatmentCompletedNCT04028479
- Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue SarcomasActive, not recruitingNCT04028063Phase 2
- Chidamide Combined With Toripalimab in SarcomaCompletedNCT04025931Phase 2
- Accuracy of Deep-learning Algorithm for Detection and Risk Stratification of Lung NodulesCompletedNCT04022512
- Apatinib Mesylate Combined With Doxorubicin and Ifosfamide in Advanced Soft-tissue SarcomaStatus unknownNCT04012827Phase 2
- Prospective Identification of Predictive Biomarkers of Trabectedin Efficacy in Non-L Soft-tissue Sarcoma PatientsCompletedNCT04008238Not applicable
- A Phase 1/2 Study of CYT-0851 in B-Cell Malignancies and Advanced Solid TumorsCompletedNCT03997968Phase 1/2
- Olaratumab (LY3012207) Patient Access for Soft Tissue SarcomaApproved for marketingNCT03994627
- Intratumoral Injection of IP-001 Following Thermal Ablation in Patients With Advanced Solid Tumors.CompletedNCT03993678Phase 1/2
- Hypofractionated Radiotherapy With Hyperthermia in Unresectable or Marginally Resectable Soft Tissue SarcomasStatus unknownNCT03989596Phase 2
- Olaratumab Plus Trabectedin in Advanced Soft-tissue Sarcoma Patients Soft-tissue Sarcoma PatientsActive, not recruitingNCT03985722Phase 1
- Chemotherapy-induced Necrosis in Ewing SarcomaCompletedNCT03968471
- A Study of CCT301-59 CAR T Therapy in Adult Subjects With Recurrent or Refractory Solid TumorsTerminatedNCT03960060Phase 1
- Patient Reported Outcome Measures (PROMs) With TrabectedinTerminatedNCT03959033
- A Safety Study of SGN-CD47M in Patients With Solid TumorsTerminatedNCT03957096Phase 1
- Efficacy and Safety of Anlotinib in Adjuvant Therapy for High-grade Soft Tissue SarcomaCompletedNCT03951571Phase 2
- Study of Anlotinib Hydrochloride and Toripalimab in Subjects With Unresectable or Metastatic Undifferentiated Pleomorphic SarcomaStatus unknownNCT03946943Phase 2
- Surveillance AFter Extremity Tumor surgerYActive, not recruitingNCT03944798Not applicable
- Adoptive Transfer of Tumor Infiltrating Lymphocytes for Advanced Solid CancersActive, not recruitingNCT03935893Phase 2
- Rehabilitation and Quality of Life Assessment for Soft Tissue Sarcoma Treated With Radiotherapy and SurgeryTerminatedNCT03916796Not applicable
- FLuoresence Image Guided Surgery With A VEGF-targeted Tracer in Soft-tissue Sarcomas in Humans Approach With Bevacizumab-IRDye 800CWCompletedNCT03913806Phase 1/2
- Incisional Negative Pressure Wound Therapy for Resection of Soft Tissue TumorsCompletedNCT03900078Not applicable
- Recognition of Circulating Tumor DNA in Soft Tissue SarcomaActive, not recruitingNCT03896620
- Anlotinib Maintenance Treatment for Advanced Soft Tissue SarcomaCompletedNCT03890068Phase 2
- Anlotinib Hydrochloride Combined With Liposomal Doxorubicin in the Treatment of Locally Advanced or Metastatic Soft Tissue SarcomaStatus unknownNCT03880695Phase 2
- Selinexor in Combination With Ixazomib for the Treatment of Advanced SarcomaWithdrawnNCT03880123Phase 1
- Nutritional Status in Retroperitoneal Sarcoma.CompletedNCT03877588Not applicable
- Tazemetostat Expanded Access Program for Adults With Solid TumorsNo longer availableNCT03874455
- Liposomal Bupivacaine (Exparel) in SarcomasTerminatedNCT03867188Early Phase 1
- Ex Vivo Drug Sensitivity Testing and Mutation ProfilingCompletedNCT03860376
- Expanded Access of Vigil in Solid TumorsTemporarily not availableNCT03842865
- Randomized Trial in Advanced, Metastatic or Unresectable Soft Tissue Sarcoma After Failure of Standard Treatments.CompletedNCT03838744Phase 2
- Epithelioid Sarcoma Natural History StudyCompletedNCT03837678
- Study of a Cohort of Cases of Synovial Sarcoma Treated in the Orthopedic Surgery and Traumatology Department of the Hospital de Sant Pau Between 1983 and 2016CompletedNCT03833037
- Anlotinib Hydrochloride Combined With Epirubicin and Ifosfamide for Soft Tissue Sarcoma PatientsStatus unknownNCT03815474Phase 2
- A Study of Pemetrexed Plus Cisplatin in Patients With Refractory Soft Tissue SarcomaCompletedNCT03809637Phase 2
- A Study of Durvalumab in Combination With Doxorubicin for Advanced Soft Tissue SarcomaCompletedNCT03802071Phase 1/2
- Study of Exosomes in Monitoring Patients With Sarcoma (EXOSARC)CompletedNCT03800121
- Radiomics for Tumor Grading of Soft Tissue Sarcomas.CompletedNCT03798795
- A Study of Pazopanib and Durvalumab for Metastatic Soft Tissue SarcomaCompletedNCT03798106Phase 2
- Phase II Study of Regorafenib as Maintenance TherapyCompletedNCT03793361Phase 2
- Radical Resection and HIPEC for Recurrent Retroperitoneal SarcomaActive, not recruitingNCT03792867Not applicable
- Anlotinib Hydrochloride For Advanced Soft Tissue Sarcoma Patients Who Do Not Receive ChemotherapyStatus unknownNCT03792542Phase 2
- Molecular Profiling of Advanced Soft-tissue SarcomasCompletedNCT03784014Phase 3
- Study of Adoptive Immunotherapy in Relapsed and Non-resectable Sarcomas After Multimodal Treatment.WithdrawnNCT03782363Phase 1
- SM-88 Maintenance Therapy for Advanced Ewing's Sarcoma and as Salvage Therapy for SarcomaActive, not recruitingNCT03778996Phase 2
- Study on Leiomyosarcoma, Liposarcomas and Synovial Sarcoma With TrabectedinWithdrawnNCT03773510Phase 3
- Metabolic Characteristics of Sarcoma In Vivo Using HP 13-C Magnetic Resonance Spectroscopic Imaging (MRSI)WithdrawnNCT03759704
- A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)CompletedNCT03752398Phase 1
- Clinical Evaluation of Neoadjuvant Chemotherapy for Primary Malignant Sarcomas That Originate in BoneCompletedNCT03742063
- Quality of Life in Patients With Non-adipocyte Soft Tissue Sarcoma Under Palliative Chemotherapy or PazopanibTerminatedNCT03735758Phase 4
- FMISO PET/CT Imaging Trial for Assessing Hypoxia in Soft Tissue SarcomasTerminatedNCT03730077Phase 1
- CBL0137 in Treating Patients With Advanced Extremity Melanoma or SarcomaTerminatedNCT03727789Phase 1
- APX005M and Doxorubicin in Advanced SarcomaCompletedNCT03719430Phase 2
- OlaReDo - Olaratumab and Rechallenge With Doxorubicin in Soft Tissue Sarcoma PatientsTerminatedNCT03698227Phase 2
- Clinical Trial of Safety, Tolerability and Antitumor Activity of Genetically Engineered T Cells in Combination With Anti-Cancer Agents in Relapsed and Refractory Synovial Sarcoma Expressing New York Esophageal Antigen-1 (NY-ESO-1) and/or LAGE-1aWithdrawnNCT03697824Phase 2
- Evaluation of Adaptive Radiation Therapy in Pre-operative or Exclusive Radiation Therapy for Limb Soft Tissues SarcomasStatus unknownNCT03680430Not applicable
- 9-ING-41 in Patients With Advanced CancersActive, not recruitingNCT03678883Phase 2
- Etiosarc: Environmental Aetiology of Sarcomas From a Multicenter French Population-based Case-control Study Among AdultsCompletedNCT03670927
- Itacitinib in Treating Patients With Refractory Metastatic/Advanced SarcomasTerminatedNCT03670069Phase 1
- Spine and Tumor Screening and SupplementationWithdrawnNCT03660540Not applicable
- T2* MRI Analysis for SarcomaCompletedNCT03658343
- Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk WallStatus unknownNCT03651375Phase 2
- C7R-GD2.CART Cells for Patients With Relapsed or Refractory Neuroblastoma and Other GD2 Positive Cancers (GAIL-N)Active, not recruitingNCT03635632Phase 1
- Photoacoustic Imaging in Diagnosing Changes in Tumors in Participants With Breast Cancer, Sarcoma, Skin Cancer, or Soft Tissue Malignancy and Healthy VolunteersTerminatedNCT03630601Not applicable
- Diagnosis and Definition of Local Involvement of Musculoskeletal Tumors: Assessment of Ultra-high Field MRI Exploration ContributionStatus unknownNCT03628274Not applicable
- Nivolumab or Nivolumab and Azacitidine in Patients With Recurrent, Resectable OsteosarcomaActive, not recruitingNCT03628209Phase 1
- Validation of a Genetic Signature to Predict the Development of SarcomasCompletedNCT03625791
- Clinical Trial in Chinese Patients of Elapsed/Metastatic/Unresectable Alveolar Soft Part Sarcoma(GB226)Status unknownNCT03623581Phase 2
- HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy.Status unknownNCT03621332
- EGFR806 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young AdultsActive, not recruitingNCT03618381Phase 1